Study of hemostasis in pediatric patients with portal vein thrombosis

Area of Science:

• Pediatric Hematology
• Thrombosis Research
• Coagulation Science

Background:

• Investigating hemostatic variables in pediatric portal vein thrombosis (PVT).
• Comparing coagulation profiles of children with PVT to a healthy pediatric control group.
• Assessing the role of hereditary deficiencies in protein C (PC) and protein S (PS) as etiological factors in pediatric PVT.

Discussion:

• Hereditary protein C or protein S deficiency was ruled out as a cause for PVT in the studied pediatric cohort.
• Evidence of minor coagulation factor consumption (factors II, V, fibrinogen) was detected in children with PVT.
• Signs of hyperfibrinolysis were present in pediatric patients experiencing PVT.
• The presence of lupus anticoagulant (LA) was noted in one pediatric case of PVT.

Key Insights:

• Pediatric portal vein thrombosis is not associated with inherited protein C or S deficiencies.
• Coagulation factor consumption and hyperfibrinolysis are subtly present in pediatric PVT.
• Lupus anticoagulant is a potential, though infrequent, finding in pediatric PVT.

Outlook:

• Further research into the specific mechanisms of hyperfibrinolysis in pediatric PVT.
• Investigating the clinical significance of minor coagulation factor consumption in pediatric thrombosis.
• Exploring the role of acquired thrombophilic factors, such as lupus anticoagulant, in pediatric PVT etiology.